The Scientific World Journal / 2012 / Article / Tab 5

Research Article

Polyvascular Disease in Patients Presenting with Acute Coronary Syndrome: Its Predictors and Outcomes

Table 5

Clinical profiles, admission therapy, and outcomes in men and women.

ACS alonePolyvascular disease
MenWomenP valueMenWomenP value

Age (yrs, mean) 5 5 ± 1 2 6 1 ± 1 2 0.001 6 4 ± 1 2 6 5 ± 1 3 0.19
Diabetes mellitus %35510.00163740.03
Hypertension %40.5640.00176810.24
Dyslipidemia %34440.00153630.55
Smoking %65100.00157160.001
Renal failure %350.00116130.44
Admission therapy (%)
 Aspirin98.698.50.7596970.51
 Clopidogrel79640.00182790.51
 Beta blockers76710.00170630.11
 ACE inhibitors71720.7270650.31
 Heparin58590.9841370.50
 Glycoprotein inhibitors8.35.20.001960.23
 Statin95940.0192940.57
 PCI23190.011310.50.55
Outcomes (%)
 Reischemia14180.00121270.17
 Heart failure10.715.50.00129340.28
 Hospital mortality3.76.30.0018.610.80.46
 1-month mortality6.89.70.00115200.26
 12-month mortality10.3150.00123290.22

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.